Navigation Links
Summary Judgment Granted for SEROQUEL(R) Patent Litigation
Date:7/1/2008

ure, tachycardia, diaphoresis, and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. The management of NMS should include immediate discontinuation of antipsychotic drugs.

Leukopenia, neutropenia, and agranulocytosis (including fatal cases), have been reported temporally related to atypical antipsychotics, including SEROQUEL. Patients with a pre-existing low white blood cell (WBC) count or a history of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these patients, SEROQUEL should be discontinued at the first sign of a decline in WBC absent other causative factors. Patients with neutropenia should be carefully monitored, and SEROQUEL should be discontinued in any patient if the absolute neutrophil count is < 1000/mm3.

Tardive dyskinesia (TD), a potentially irreversible syndrome of involuntary dyskinetic movements, may develop in patients treated with antipsychotic drugs. The risk of developing TD and the likelihood that it will become irreversible are believed to increase as the duration of treatment and total cumulative dose of antipsychotic drugs administered to the patient increase. TD may remit, partially or completely, if antipsychotic treatment is withdrawn. SEROQUEL should be prescribed in a manner that is most likely to minimize the occurrence of TD.

Warnings and Precautions also include the risk of orthostatic hypotension, cataracts, seizures, hyperlipidemia, and possibility of suicide attempts. Examination of the lens by methods adequate to detect cataract formation, such as slit lamp exam or other appropriately sensitive methods, is recommended at initiation of treatment or shortly thereafter, and at 6-month intervals during chronic treatment. The possibility of a suicide attempt is inherent in schizophrenia, and close supervision of high risk patients sho
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
4. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
5. Par Pharmaceutical Provides Summary of Analyst/Investor Day
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
8. Exercising judgment: The psychology of fitness
9. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
10. St. Davids HealthCare Granted the States Top Honor for Quality and Performance Excellence
11. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... GA (PRWEB) February 27, 2015 ... Martin Ventures, is collaborating with the Atlanta-based software ... the adoption of Jvion’s advanced predictive capabilities suite ... analytics company that identifies and prevents financial and ... need for predictions that help prevent patient deterioration ...
(Date:2/27/2015)... February 27, 2015 Aligned Modern ... local neighborhood health centers, officially welcomes Dr. Alaina ... based in Aligned Modern Health’s Lincoln Square, Streeterville, ... from the National University of Health Sciences and ... She has completed post-graduate coursework in functional ...
(Date:2/27/2015)... Connecticut Community for Addiction Recovery (CCAR) recently received an ... Centers (ADRC), for its shared Recovery Oriented Employment Services ... 2014 Commissioner’s Recognition Award by the CT Department of ... ROES achieved the highest rate of employment in its ... and other drug addiction. More than half of ...
(Date:2/27/2015)... GA (PRWEB) February 27, 2015 Leading ... and Consumer Protection, PartnerTech Inc. President, Gary ... Association of Georgia (TAG) for the TechAmerica DC ... leaders on legislation regarding technology along with the opportunity ... manufacturer of technology driven products, evidenced by their current ...
(Date:2/27/2015)... Bird B Gone, the leader in ... now offers an effective and humane combo of ... to this bird problem. Rarely have two new products ... problem. , Sparrow Charmer™ Bird Caller Lures them , ... broadcasting Bird B Gone’s proprietary sparrow call. Field tested ...
Breaking Medicine News(10 mins):Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:Chicago Wellness Centers Welcomes New Lead Functional Medicine Doctor to Staff 2Health News:Chicago Wellness Centers Welcomes New Lead Functional Medicine Doctor to Staff 3Health News:PartnerTech Joins Technology Association of Georgia for TechAmerica DC Fly-In 2Health News:PartnerTech Joins Technology Association of Georgia for TechAmerica DC Fly-In 3Health News:New Sparrow Charmer & Sparrow Sky Trap Combo Delivers One-Two Punch to Sparrow Problem 2Health News:New Sparrow Charmer & Sparrow Sky Trap Combo Delivers One-Two Punch to Sparrow Problem 3
... International Symposium on GnRH Analogs in Cancer and ... of fertility drugs. Organon scientists have succeeded in ... hybrid subunit, which extends FSH's active life. This ... active life will mean fewer injections for the ...
... has stated that there is a metabolic threshold that ... activity becomes deleterious for lumbar bone mineral density (LBMD) ... a 10-year period, investigated the longitudinal relationship between daily ... women. They assessed LMBD, habitual daily physical activity, total ...
... of all newly-diagnosed lung cancer cases. Smoking inflicts serious damage ... people quit, as it takes time for the tissue to ... damage in the form of loss of a gene that ... of Texas have now shown that a close chemical relative ...
... the University of Rochester, New York suggests that the ... anti-coagulant properties,which until now is being used to treat ... by stroke. Researchers who conducted the study on mice ... secondary damage associated with ischemic stroke by preventing apoptosis, ...
... But it is no term to be happy about, because ... which could affect those individuals whose work or lifestyle demands ... Sitting for a long time without a break could cause ... into the lungs with possible fatal consequences. This condition is ...
... the Harvard School of Public Health now reveals that caregiving ... found that women who care for a disabled or ill ... findings were reported from a long-running Nurses' Health Study, which ... 54,412 women aged between 46 and 71. They found that ...
Cached Medicine News:Health News:New fertility drug development techniques by Organon 2
(Date:2/26/2015)... February 26, 2015 The ... Bottle washer, Filler, Capper, Blow molder, Shrink wrapper), ... (Still, Flavored, Sparkling) & Region - Trends & ... segments the bottled water processing market with analyses ... terms of value. It also identifies the driving ...
(Date:2/26/2015)... 2015 People with psoriasis and their ... participate in research that aims to improve treatments ... psoriasis registry begins recruiting patients in 2015. ... National Psoriasis Foundation and Corrona, LLC, will initially ... new biologic medication by Novartis Pharmaceuticals for moderate-to-severe ...
(Date:2/26/2015)... Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... Company 35 th Annual Health Care Conference on Wednesday, ... Boston Marriott Copley Place. A live webcast of the presentation ... be available approximately one hour after the presentation. ...
Breaking Medicine Technology:Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
... mounts on a standard ring stand rod ... 1/2" ) mounting rod. The 14cm (5 ... the source of fumes. A top connector ... to an aspirator or vacuum source. Tubing, ...
... These corrosion proof polypropylene exhaust hoods are ... of tanks and draw a stream of ... away from the operator. Other sizes and ... lateral, and double-slot are available on special ...
... The Benchtop Fume Hood is an ... installations in which a number of fume ... schools, junior colleges and universities. Features include ... polyethylene with rounded inside corners for easy ...
Medicine Products: